Incannex Healthcare Files S-1 for Public Offering

TL;DR

Incannex Healthcare just filed an S-1, looks like they're going public!

AI Summary

Incannex Healthcare Inc. filed an S-1 registration statement on July 3, 2024, to register securities under the Securities Act of 1933. The company, incorporated in Delaware and operating in the Pharmaceutical Preparations sector (SIC 2834), is based in Docklands, Victoria, Australia. This filing indicates their intent to offer shares to the public, marking a significant step in their corporate development.

Why It Matters

This S-1 filing is a crucial step for Incannex Healthcare Inc. as it signals their intention to raise capital by offering their securities to the public, potentially impacting their growth and market presence.

Risk Assessment

Risk Level: medium — As a company filing an S-1, Incannex Healthcare is undergoing the process of becoming publicly traded, which inherently involves market and regulatory risks.

Key Numbers

• 333-280670 — SEC File Number (Identifies the specific SEC registration)
• 0001873875 — Central Index Key (Unique identifier for the company in SEC filings)

Key Players & Entities

• Incannex Healthcare Inc. (company) — Registrant
• July 3, 2024 (date) — Filing Date
• Securities Act of 1933 (legal_document) — Governing Legislation
• Delaware (jurisdiction) — State of Incorporation
• 2834 (sic_code) — Pharmaceutical Preparations SIC Code
• George Anastassov (person) — Director

FAQ

Key Financial Figures

• $0 — d to the public in this offering, minus $0.001, and the exercise price of each pre
• $0.001 — rice of each pre-funded warrant will be $0.001 per share. The pre-funded warrants will
• $1.235 billion — e Act, our annual gross revenues exceed $1.235 billion or we issue more than $1.0 billion of n
• $1.0 billion — ed $1.235 billion or we issue more than $1.0 billion of non-convertible debt in any three-ye
• $250.0 million — ock held by non-affiliates is less than $250.0 million measured on the last business day of ou
• $100.0 million — ter, or our annual revenue is less than $100.0 million during the most recently completed fisc
• $700.0 million — ock held by non-affiliates is less than $700.0 million measured on the last business day of ou

Filing Documents

• ea0208793-s1_incannex.htm (S-1) — 2291KB
• ea020879301ex23-1_incannex.htm (EX-23.1) — 2KB
• ea020879301ex-fee_incannex.htm (EX-FILING FEES) — 16KB
• image_001.jpg (GRAPHIC) — 6KB
• image_002.jpg (GRAPHIC) — 29KB
• image_003.jpg (GRAPHIC) — 36KB
• image_004.jpg (GRAPHIC) — 26KB
• image_005.jpg (GRAPHIC) — 21KB
• image_006.jpg (GRAPHIC) — 28KB
• image_007.jpg (GRAPHIC) — 31KB
• image_008.jpg (GRAPHIC) — 39KB
• image_009.jpg (GRAPHIC) — 22KB
• image_010.jpg (GRAPHIC) — 46KB
• image_011.jpg (GRAPHIC) — 66KB
• image_012.jpg (GRAPHIC) — 40KB
• image_013.jpg (GRAPHIC) — 40KB
• image_014.jpg (GRAPHIC) — 23KB
• image_015.jpg (GRAPHIC) — 28KB
• image_016.jpg (GRAPHIC) — 33KB
• image_017.jpg (GRAPHIC) — 20KB
• image_018.jpg (GRAPHIC) — 90KB
• image_019.jpg (GRAPHIC) — 99KB
• image_020.jpg (GRAPHIC) — 35KB
• image_021.jpg (GRAPHIC) — 37KB
• image_022.jpg (GRAPHIC) — 35KB
• image_023.jpg (GRAPHIC) — 33KB
• image_024.jpg (GRAPHIC) — 32KB
• 0001213900-24-058785.txt ( ) — 9826KB
• ixhl-20240331.xsd (EX-101.SCH) — 70KB
• ixhl-20240331_cal.xml (EX-101.CAL) — 37KB
• ixhl-20240331_def.xml (EX-101.DEF) — 310KB
• ixhl-20240331_lab.xml (EX-101.LAB) — 436KB
• ixhl-20240331_pre.xml (EX-101.PRE) — 326KB
• ea0208793-s1_incannex_htm.xml (XML) — 853KB

Use of Proceeds

Use of Proceeds 30 Dividend Policy 30 Capitalization 31

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 33

Business

Business 42 Management 98 Executive and Director Compensation 103 Certain Relationships and Related Party Transactions 111 Principal Stockholders 112

Description of Capital Stock

Description of Capital Stock 113

Description of Securities We Are Offering

Description of Securities We Are Offering 116 Material United States Federal Income Tax Consequences 120 Plan of Distribution 126 Legal Matters 128 Experts 128 Where You Can Find More Information 128 You should rely only on the information contained in this prospectus and any related free-writing prospectus that we authorize to be distributed to you. We have not authorized any person to provide you with information different from that contained in this prospectus or any related free-writing prospectus that we authorize to be distributed to you. This prospectus is not an offer to sell, nor is it seeking an offer to buy, these securities in any state where the offer or sale is not permitted. The information in this prospectus speaks only as of the date of this prospectus unless the information specifically indicates that another date applies, regardless of the time of delivery of this prospectus. No action is being taken in any jurisdiction outside the United States to permit a public offering of the securities or possession or distribution of this prospectus in that jurisdiction. Persons who come into possession of this prospectus in jurisdictions outside the United States are required to inform themselves about and to observe any restrictions as to this offering and the distribution of the prospectus applicable to that jurisdiction. i Trademarks We own or have rights to trademarks and trade names that we use in connection with the operation of our business, including our corporate name, logos, product names and website names. Solely for your convenience, some of the trademarks and trade names referred to in this prospectus are listed without the and TM symbols, but we will assert, to the fullest extent under applicable law, our rights to our trademarks and trade names. S tatistical and O ther I ndustry and M arket D ata This prospectus includes statistical and other industry and market data and contains estimates and information c

View Full Filing

View this S-1 filing on SEC EDGAR